LIPID CONTROL AND USE OF LIPID-LOWERING DRUGS FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN TAIWAN: THE TAIWANESE SECONDARY PREVENTION FOR PATIENTS WITH ATHEROSCLEROTIC DISEASE (T-SPARCLE) REGISTRY | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Basic and Translational Medicine

Basic research of cardiovascular disease

GW23-e2638

LIPID CONTROL AND USE OF LIPID-LOWERING DRUGS FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN TAIWAN: THE TAIWANESE SECONDARY PREVENTION FOR PATIENTS WITH ATHEROSCLEROTIC DISEASE (T-SPARCLE) REGISTRY

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Yin W, Yin W

LIPID CONTROL AND USE OF LIPID-LOWERING DRUGS FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN TAIWAN: THE TAIWANESE SECONDARY PREVENTION FOR PATIENTS WITH ATHEROSCLEROTIC DISEASE (T-SPARCLE) REGISTRY

Heart 2012;98:E10-E11.